Back
CBRE Group Vs. Avidity Biosciences Industry Stock Comparison
Buy
84
CBRE
CBRE Group
Last Price:
122.49
Seasonality Move:
5.72%
Sell
33
RNA
Avidity Biosciences
Last Price:
45.67
Seasonality Move:
-1.3%
Buy
84
CBRE Group (CBRE)
is a Buy
Is CBRE Group a Buy, Sell or Hold?
- The current CBRE Group [CBRE] share price is $122.49. The Score for CBRE is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- CBRE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
33
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $45.68. The Score for RNA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CBRE Stock Price Chart
What is CBRE Group's stock price today?
-
The CBRE Group share price today is $122.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CBRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $45.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
CBRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.99 | Buy |
Relative Strength Index (14 RSI): | 74.59 | Buy |
Chaikin Money Flow: | 1637724 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (112.7 - 118.44) | Buy |
Bollinger Bands (100): | (86.79 - 111.31) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 62 | Buy |
Chaikin Money Flow: | 402350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.19 - 44.69) | Buy |
Bollinger Bands (100): | (30.3 - 45.36) | Buy |
CBRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 118.82 | Buy |
20-day SMA: | 116.54 | Buy |
50-day SMA: | 110.06 | Buy |
200-day SMA: | 94.28 | Buy |
8-day EMA: | 119.06 | Buy |
20-day EMA: | 116.37 | Buy |
50-day EMA: | 110.11 | Buy |
200-day EMA: | 96.14 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.33 | Buy |
20-day SMA: | 42.39 | Buy |
50-day SMA: | 43.82 | Buy |
200-day SMA: | 26.96 | Buy |
8-day EMA: | 43.04 | Buy |
20-day EMA: | 42.7 | Buy |
50-day EMA: | 41.84 | Buy |
200-day EMA: | 30.49 | Buy |
CBRE Group Earnings Growth & CBRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $0.34 per share, an increase this year of $1.14 per share, and an increase next year of $1.10 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
CBRE Group Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |